Another frequent missense variant was ERBB2 p.(Ile655Val), which was classified in 21 of 53 (40%) TET patients (16 of 34 [47%] thymic carcinomas and 5 of 19 [26%] thymomas) as homozygous or heterozygous. Here, ERBB2 is linked to thymoma.